Li et al. (88) found that the expression of METTLE3 is significantly increased in primary CRC tissues compared with adjacent normal tissues and that METTL3 is significantly elevated in corresponding lymph node and liver metastatic foci. This evidence concerns the gene METTL3 and colorectal carcinoma.